News & Blog

Author Archives: Tom Halkin

Moving The Field Toward More Patient-Focused Drug Development

Together with our partners in the Jumpstarting Brain Tumor Drug Development Coalition – Accelerate Brain Cancer Cure (ABC2), Musella Foundation for Brain Tumor Research and Education, and the Society for Neuro-Oncology – NBTS has been advocating for the brain tumor research field to take patients’ quality of life into great account during clinical trials. As […]

So You Heard About Rintega? Here’s What’s Next for Brain Tumor Drug Development

Last week, news broke that a promising clinical trial of a new type of treatment for a subset of glioblastoma (GBM) patients – an immunotherapeutic vaccine made by Celldex Therapeutics called RINTEGA (rindopepimut) – was discontinued because patients receiving the investigational therapy were not doing better than patients in the control arm. As we said in our statement regarding […]

Guest Blog: Team Sherif’s Sheriffs Returns the Favor to Influential Doctor

He looked at me, he looked me square in the eyes, and he said, “Steve, do you know why we study?” I was on my second day of my first job in emergency medicine and I knew I would receive a lot probing questions to see how qualified I was. This one seemed simple, so […]

Share